Daiichi Sankyo
Daniel BARRIOS is a seasoned professional in clinical development with a focus on oncology. Currently serving as Senior Director of Clinical Development Oncology at Daiichi Sankyo, Inc. since April 2019, BARRIOS also holds the position of Clinical Program Director at Pierre Fabre. Prior experience includes roles at Novartis as a Medical Scientific Expert and Medical Advisor for the Solid Tumors Franchise between 2011 and 2016, with a focus on early-phase drug development in breast cancer. BARRIOS completed a fellowship at Gustave Roussy from 2008 to 2012 and holds specialized oncology qualifications from Université Paris Descartes and Université Paris-Sud. BARRIOS began medical training at Universidad Mayor de San Andres, graduating in 2007.
This person is not in any teams
This person is not in any offices
Daiichi Sankyo
21 followers
Daiichi Sankyo Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Daiichi Sankyo Group and Ranbaxy Group. The Daiichi Sankyo Group segment comprises of Daiichi Sankyo Co., Ltd. and its subsidiaries. The Ranbaxy Group segment includes its core company, Ranbaxy Laboratories Ltd. Both group segments deal with business activities in prescription drugs and general pharmaceutical products. The company was founded on September 28, 2005 and is headquartered in Tokyo, Japan.